# Great Point Partners invests in Tergus Pharma for new facility

Great Point Partners completed a growth equity investment in Tergus Pharma to build a new 100,000 sq ft commercial manufacturing facility in Raleigh, NC, expanding capacity by over 400%.

- Type: Investment
- Announced: 2019-06-08
- Where: Raleigh, North Carolina, United States
- Starts operating: Jul 2019
- Status: announced
- Capacity: 100,000 square foot facility, over 400% capacity increase
- Products: topical dermatology pharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Tergus Pharma](https://endata.com/companies/39854.md)
- [Great Point Partners](https://endata.com/companies/39855.md) (investor)

## Sources

- [prweb.com](https://www.prweb.com/releases/Great_Point_Partners_Completes_Growth_Equity_Investment_in_Tergus_Pharma_to_Build_New_100_000_Square_Foot_Manufacturing_Facility_for_Topical_Pharmaceuticals/prweb16362959.htm), 2019-06-08: "The equity capital from GPP will enable us to do this and we will be able to better serve our customers by offering end-to-end services including commercial manufacturing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.